Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for

Volume 4, Issue 2, Page 1 (February 2009)


View previous. 3 of 24 View next.

Emerging Thyroid Cancer Therapies Show Promise

MICHELE G. SULLIVAN (Mid-Atlantic Bureau)

Kinase inhibitors and antiangiogenic drugs may offer the first real hope of treating differentiated metastatic thyroid cancer, and seem to be especially effective in tumors exhibiting the B-type Raf kinase mutation.

PII: S1558-0164(09)70035-5

doi:10.1016/S1558-0164(09)70035-5


View previous. 3 of 24 View next.